Rashidul Haque & Sultana Rajia 2023. AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes. Research Highlights in Disease and Health Research Vol. 2. (Feb. 2023), 83–95. DOI:https://doi.org/10.9734/bpi/rhdhr/v2/9366F.